United States (US) Molecular Diagnostics Market Forecast

1
United States Molecular Diagnostics Market
Category Drugs Pharmaceuticals
2
United States Molecular Diagnostics Market
Forecast Analyst View United States molecular
diagnostics market is anticipated to cross US 9
billion by the end of year 2024. Get 10 Free
Customization in this Report Press Release
Title United States (US) Molecular Diagnostics
Market to be more than USD 9 Billion by 2024 For
More Information http//www.renub.com/united-stat
es-us-molecular-diagnostics-market-to-be-more-than
-usd-9-billion-by-2024-52-nd.php  

3
United States (US) Molecular Diagnostics Market
to be more than USD 9 Billion by 2024
Access Full Research http//www.renub.com/united-
states-usa-molecular-diagnostics-market-test-volum
e-forecast-and-companies-35-p.php In the United
States, Cancer is a leading cause of death that
can be detected early because of molecular
diagnostic tests. This is why the molecular
diagnostics is the primary growth driver for this
market. United States molecular diagnostics
market is anticipated to cross US 9 billion by
the end of year 2024.   Utilization of
molecular diagnostics which help to reduce
healthcare costs for patients by avoiding
unnecessary drugs, medical care, and
chemotherapy. It is also useful to detect cancer
biomarkers to improve the survival rate of
patients. The capability of molecular diagnostics
to authenticate cancer biomarkers and improve
patient care will lead to the growth of this
market during the projected period.  

4
The United States leads the regional market for
blood screening and blood products
Presently, in the field of medical diagnostics,
molecular diagnostics for cancer test offers one
of the key areas for innovation and expansion.
Molecular oncology tests have emerged as a
substantial market segment. The United States
leads the regional market for blood screening and
blood products. Molecular diagnostics is also a
significant tool for Food Pathogen Detection
Testing and HLA Testing as well as other
diseases. Characterization Application of the
United State Molecular Diagnostics Market The
United States molecular diagnostics market based
on application the market is broadly
characterized into Oncology Test, Infectious
diseases, Genetic tests. The Oncology molecular
diagnostics market is determined by technological
advancements, growing prevalence of cancer, and
rising focus on personalized medicine.  

5
6 Countries Multiple Sclerosis Market Patients
Treated Studied in the Report
In the current scenario diagnostics market,
molecular diagnostics for infectious disease test
offers one of the dazzling areas for innovation
and growth. The most prevailing and profitable
sector is expected to continue to rise in
Infectious diseases. The innovations in molecular
technologies continue to improve and grow and
also reduce the time span it takes to diagnose
infectious disease. Showcasing the rising
technologies from both research laboratories and
clinical, the Molecular Diagnostics for
Infectious Disease conference is now in its ninth
year in Washington, DC. A new diagnostic
approach that may considerably change the
practice of medicine is the expansions
in genomicsand proteomics. Recognize genetic and
chromosomal variations that are related to
disease or risk states are Genetic test.
Molecular diagnostics are multifaceted laboratory
techniques that analyze and identify biomarkers,
genetic sequences, metabolites and other
molecules. Helping patients and their doctors
identify individuals with a susceptibility to a
particular disease, identify whether the patients
have a disease at earlier stages of illness,
evaluate the efficiency of an exacting drug
therapy for an individual and describes the
accurate nature of a disease. 

6
Get 10 Free Customization in this Report
Oncology Test has been classified into four main
categories Breast Cancer Test, Colorectal Cancer
Test, Prostate Cancer Test and Other Cancer Test.
Infectious Disease Test has been classified into
four main categories, namely, Virology, HAI, HPV
and Critical Care Test and Genetic Test has been
segmented into Blood Screening, HLA and Food
Pathogen Test. Genetic test drives all way ahead
from Infectious and Oncology Test owing to Food
Pathogen Test Volume. Breast cancer is dominating
the market share of Oncology Test and Virology
leads all other segments of share in the
Infectious test market.   Request a free sample
copy of the report http//www.renub.com/contactus
.php   United State Molecular diagnostics Market
Reimbursement policy  United States
reimbursement policy is a considerable
determinant for commercial success in the
molecular diagnostics market.

7
Challenges in the United States Molecular
Diagnostics Market
Physicians more often than not adopt a diagnostic
regardless of its clinical validity due to lack
of sufficient reimbursement. Proper reimbursement
emphasizes on to the payers choice to cover the
diagnostics and the reimbursement that they
provide. A diagnostics for reimbursement by
Centers for Medicare and Medicaid Services (CMS)
for Medical health, Medicaid, and Veteran
patients is the most important reimbursement
function. The main insurer in the United State is
(CMS) Centers for Medicare and Medicaid Services,
and many payers follow its reimbursement
decisions. In recent times, the legislation was
proposed (Medicare Advanced Laboratory
Diagnostics Act of 2007) to develop the
reimbursement process for molecular diagnostics
in the United States. Challenges in the United
States Molecular Diagnostics Market   
 Reimbursement Capabilities Without sufficient
reimbursement, physicians generally will not
adopt a diagnostic regardless of its clinical
validity.

8
Challenges in the United States Molecular
Diagnostics Market
Sufficient reimbursement depends on whether or
not payors choose to cover the diagnostic and the
level of reimbursement that they offer.   
 Regulatory Issues The regulatory environment is
a vital modulating factor for the pharmaceutical
and diagnostics industry. One of the other key
constraints on the successful and widespread
adoption of the novel diagnostic tools involves
government regulation of molecular diagnostic
assays.     Quality Checkpoints, Awareness
Acceptance Methodologies are changed rapidly,
making it difficult for the companies to develop
standard materials to maintain the quality of the
tests. Given the expense of the tests and
materials, various laboratories have been less
willing to pay more for the controls. Quality is
developed only after new tests are implemented
and are standardized.

9
Table of Contents for US Molecular Diagnostics
Market
1. Executive Summary   2. United States
Molecular Diagnostics Market Forecast   3.
United States Molecular Diagnostics Test Volume
Forecast   4. United States Molecular
Diagnostics Market Share (2010 2024)   5.
United States Molecular Diagnostics Test Volume
Share (2010 2024)   6. Segments United
States Molecular Diagnostics Market (2010
2024)   7. Segments United States Molecular
Diagnostics Test Volume (2010 2024)   8.
Company United States Molecular Diagnostics
Sales Forecast   9. Growth Factors   10.
Challenges

10
Get 10 Free Customization in this Report
Diagnostics Market Report http//www.renub.com/
diagnostics-14-c.php

•  Renub Research - North America
• Rajat Gupta
• 225 Kristie Ln, Roswell
• Georgia 30076, United States
• Tel [phone]
• Email info_at_renub.com
• www.renub.com
•  
• Renub Research - Asia
• Ankit Mishra
• C 86, Sector 10
• Noida 201301, India
• Tel [phone]